189 related articles for article (PubMed ID: 35803110)
1. Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
Allen JL; Hames RA; Mastroianni NM; Greenstein AE; Weed SA
Oral Oncol; 2022 Sep; 132():106008. PubMed ID: 35803110
[TBL] [Abstract][Full Text] [Related]
2. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
Hira-Miyazawa M; Nakamura H; Hirai M; Kobayashi Y; Kitahara H; Bou-Gharios G; Kawashiri S
Int J Oncol; 2018 Feb; 52(2):379-388. PubMed ID: 29345283
[TBL] [Abstract][Full Text] [Related]
3. Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop.
Hayes KE; Walk EL; Ammer AG; Kelley LC; Martin KH; Weed SA
Oncogene; 2013 Oct; 32(40):4766-77. PubMed ID: 23146907
[TBL] [Abstract][Full Text] [Related]
4. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
[TBL] [Abstract][Full Text] [Related]
5. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics.
Prieto-Fernandez L; Villaronga MLA; Hermida-Prado F; Hijazi M; Montoro-Jimenez I; Pevida M; Llames S; Rodrigo JP; Cutillas P; Calvo F; Garcia-Pedrero JM; Alvarez-Teijeiro S
Biomed Pharmacother; 2023 Feb; 158():114176. PubMed ID: 36916400
[TBL] [Abstract][Full Text] [Related]
6. ALIX promotes cell migration and invasion of head and neck squamous cell carcinoma by regulating the expression of MMP9, MMP14, VEGF-C.
Xie QH; Wang WM; Yang JG; Xia HF; Xiao BL; Chen GH; Huang J; Li RF; Chen G
Arch Oral Biol; 2023 Jul; 151():105696. PubMed ID: 37086494
[TBL] [Abstract][Full Text] [Related]
7. DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma.
Arnold L; Yap M; Jackson L; Barry M; Ly T; Morrison A; Gomez JP; Washburn MP; Standing D; Yellapu NK; Li L; Umar S; Anant S; Thomas SM
bioRxiv; 2024 Apr; ():. PubMed ID: 38645056
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells.
Johansson AC; Ansell A; Jerhammar F; Lindh MB; Grénman R; Munck-Wikland E; Östman A; Roberg K
Mol Cancer Res; 2012 Sep; 10(9):1158-68. PubMed ID: 22809838
[TBL] [Abstract][Full Text] [Related]
9. Early stage mechanical remodeling of collagen surrounding head and neck squamous cell carcinoma spheroids correlates strongly with their invasion capability.
Chen YQ; Kuo JC; Wei MT; Chen YC; Yang MH; Chiou A
Acta Biomater; 2019 Jan; 84():280-292. PubMed ID: 30500449
[TBL] [Abstract][Full Text] [Related]
10. Imbalance between Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Promotes Invasion and Metastasis of Head and Neck Squamous Cell Carcinoma.
Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC
Clin Lab; 2017 Oct; 63(10):1613-1620. PubMed ID: 29035450
[TBL] [Abstract][Full Text] [Related]
11. A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops.
O-Charoenrat P; Rhys-Evans P; Eccles S
Int J Cancer; 2002 Aug; 100(5):527-33. PubMed ID: 12124801
[TBL] [Abstract][Full Text] [Related]
12. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
Clark ES; Whigham AS; Yarbrough WG; Weaver AM
Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.
Aderhold C; Umbreit C; Faber A; Birk R; Sommer JU; Hörmann K; Schultz JD
Anticancer Res; 2014 Sep; 34(9):4929-37. PubMed ID: 25202075
[TBL] [Abstract][Full Text] [Related]
15. Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Umbreit C; Aderhold C; Faber A; Sauter A; Hofheinz RD; Stern-Straeter J; Hoermann K; Schultz JD
Oncol Rep; 2014 Aug; 32(2):668-76. PubMed ID: 24890748
[TBL] [Abstract][Full Text] [Related]
16. Reflux induces DNA strand breaks and expression changes of MMP1+9+14 in a human miniorgan culture model.
Sandner A; Illert J; Koitzsch S; Unverzagt S; Schön I
Exp Cell Res; 2013 Nov; 319(19):2905-15. PubMed ID: 24075964
[TBL] [Abstract][Full Text] [Related]
17. Ethanolic Extract of Ocimum sanctum Leaves Reduced Invasion and Matrix Metalloproteinase Activity of Head and Neck Cancer Cell Lines.
Utispan K; Niyomtham N; Yingyongnarongkul BE; Koontongkaew S
Asian Pac J Cancer Prev; 2020 Feb; 21(2):363-370. PubMed ID: 32102512
[TBL] [Abstract][Full Text] [Related]
18. Fenretinide combines perturbation of signaling kinases, cell-extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells.
Wang D; Pei P; Shea FF; Bissonnette C; Nieto K; Din C; Liu Y; Schwendeman SP; Lin YX; Spinney R; Mallery SR
Carcinogenesis; 2022 Oct; 43(9):851-864. PubMed ID: 35974187
[TBL] [Abstract][Full Text] [Related]
19. Induction of ALP and MMP9 activity facilitates invasive behavior in heterogeneous human BMSC and HNSCC 3D spheroids.
Wessely A; Waltera A; Reichert TE; Stöckl S; Grässel S; Bauer RJ
FASEB J; 2019 Nov; 33(11):11884-11893. PubMed ID: 31366234
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.
Jimenez L; Sharma VP; Condeelis J; Harris T; Ow TJ; Prystowsky MB; Childs G; Segall JE
Arch Pathol Lab Med; 2015 Nov; 139(11):1349-61. PubMed ID: 26172508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
